查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1608067

植入式心律管理設備市場：按裝置、最終用戶分類 - 2025-2030 年全球預測

Implantable Cardiac Rhythm Management Devices Market by Device (Cardiac Resynchronization Therapy, Defibrillators, Pacemakers), End-User (Ambulatory Surgical Centers, Hospitals, Speciality Cardiac Centers) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年植入式心律管理設備市值為135.4億美元，預計2024年將達到152.3億美元，複合年成長率為10.16%，2030年將達266.6億美元，預計將達到1000萬美元。

植入式心律管理設備市場範圍包括旨在管理心律不整的設備，例如心律調節器、心臟去顫器和心臟再同步治療設備。這些設備對於透過維持適當的心率和心率來治療心搏過緩、心搏過速和心臟衰竭至關重要。人口老化、心血管疾病盛行率的增加以及技術進步正在推動這些設備的需求和應用。最終用途包括醫院、門診手術中心和心臟中心，由於意識的提高和醫療保健設施的改善，醫院的手術量正在增加。市場成長受到設備技術創新的影響，例如 MRI 相容設備、遠端監控系統和無導線心律調節器。新興市場、不斷成長的醫療保健支出以及遠端醫療的採用帶來了機會。公司可以透過投資先進能力的研發並開拓開拓的市場來利用這些機會。然而，市場成長面臨設備成本高、監管核准嚴格以及設備相關併發症（如感染疾病和設備故障）等限制。競爭因素包括來自替代非侵入性治療方案的競爭以及某些地區的報銷問題。最佳創新領域包括開發可充電電池、增強即時健康資料分析的遠端監控功能以及提高患者舒適度和依從性的小型化或生物可吸收材料，其中包括設計等。市場是動態的，以快速的技術發展和監管變化為標誌，要求參與者保持敏捷和響應能力。透過專注於持續創新和策略夥伴關係關係，公司可以克服限制、開拓新客戶群並保持成長。因此，市場參與者應在研究中優先考慮適應性策略，遵守不斷變化的監管標準，並投資以患者為中心的解決方案，以加強其市場地位。

主要市場統計
基準年[2023] 135.4億美元
預測年份 [2024] 152.3億美元
預測年份 [2030] 266.6億美元
複合年成長率（%） 10.16%

市場動態：快速發展的植入式心律管理設備市場的關鍵市場洞察

供需的動態交互作用正在改變植入式心律管理設備市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 全球心臟病盛行率上升
    • 優惠報銷政策
    • 醫療機構採用率提高
  • 市場限制因素
    • 植入式心律管理設備高成本
  • 市場機會
    • 研發費用及新產品推出快速增加
    • 將先進技術融入CRM設備
  • 市場挑戰
    • 與CRM設備相關的操作問題

波特五力：駕馭植入式心律管理設備市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解植入式心律管理設備市場的外部影響

外部宏觀環境因素在塑造植入式心律管理設備市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解植入式心律管理設備市場的競爭格局

對植入式心律管理設備市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣植入式心律管理設備市場供應商的績效評估

FPNV定位矩陣是評估植入式心律管理設備市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，描繪植入式心律管理設備市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，植入式心律管理設備市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球心臟病發病率正在上升
      • 優惠退款政策
      • 醫療機構的採用率提高
    • 抑制因素
      • 植入式心律管理設備成本高昂
    • 機會
      • 研發費用及新產品推出快速增加
      • 將先進技術整合到 CRM 設備中
    • 任務
      • 與 CRM 設備相關的操作問題
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章植入式心律管理設備市場：依設備分類

  • 心臟再同步治療
    • CRT心臟去顫器
    • CRT心律調節器
  • 心臟去顫器
    • 體外去顫心臟去顫器
    • 植入式心臟整流去顫器
  • 心律調節器
    • 外部的
    • 凹入式

第7章 植入式心律管理設備市場：依最終使用者分類

  • 門診手術中心
  • 醫院
  • 專業心臟中心

第8章美洲植入式心律管理設備市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太植入式心律管理設備市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章：歐洲、中東和非洲植入式心律管理設備市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • BIOTRONIK SE & Co KG
  • Boston Scientific Corporation
  • Hydrix Limited
  • Japan Lifeline Co., Ltd.
  • Koninklijke Philips NV
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Stryker Corporation
Product Code: MRR-742BD517F8D1

The Implantable Cardiac Rhythm Management Devices Market was valued at USD 13.54 billion in 2023, expected to reach USD 15.23 billion in 2024, and is projected to grow at a CAGR of 10.16%, to USD 26.66 billion by 2030.

The scope of the Implantable Cardiac Rhythm Management Devices market encompasses devices like pacemakers, defibrillators, and cardiac resynchronization therapy devices designed to manage heart rhythm disorders. These devices are essential in treating bradycardia, tachycardia, and heart failure by maintaining adequate heart rates and rhythm. An increasing aging population, rising incidences of cardiovascular diseases, and technological advancements drive the necessity and application of these devices. End-use encompasses hospitals, ambulatory surgical centers, and cardiac centers where the number of procedures is escalating due to growing awareness and improved access to healthcare facilities. Market growth is influenced by innovation in device technologies such as MRI-compatible devices, remote monitoring systems, and leadless pacemakers. Opportunities arise from emerging markets, increasing healthcare expenditure, and the adoption of telemedicine. Companies can capitalize on these opportunities by investing in R&D for advanced functionalities and entering untapped markets. However, market growth faces limitations like high device costs, stringent regulatory approvals, and device-related complications such as infections or device malfunctions. The challenging factors include competition from alternative non-invasive treatment options and reimbursement issues in some regions. The best areas for innovation include developing rechargeable batteries, enhancing remote monitoring capabilities for real-time health data analysis, and designing miniaturized or bioresorbable materials to improve patient comfort and compliance. The market is dynamic, marked by rapid technological evolution and regulatory changes, requiring players to stay agile and responsive. By focusing on continuous innovation and strategic partnerships, firms can overcome constraints, tap into new customer segments, and sustain growth. Therefore, market players should prioritize an adaptable strategy in research, adhering to evolving regulatory standards and investing in patient-centric solutions to bolster their market position.

KEY MARKET STATISTICS
Base Year [2023] USD 13.54 billion
Estimated Year [2024] USD 15.23 billion
Forecast Year [2030] USD 26.66 billion
CAGR (%) 10.16%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Implantable Cardiac Rhythm Management Devices Market

The Implantable Cardiac Rhythm Management Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of cardiac diseases worldwide
    • Favorable reimbursement policies
    • Increasing adoption by the healthcare facilities
  • Market Restraints
    • High cost of implantable cardiac rhythm management devices
  • Market Opportunities
    • Surge in R&D spending and new product launches
    • Integration of advanced technologies in CRM devices
  • Market Challenges
    • Operational issues associated with CRM devices

Porter's Five Forces: A Strategic Tool for Navigating the Implantable Cardiac Rhythm Management Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Implantable Cardiac Rhythm Management Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Implantable Cardiac Rhythm Management Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Implantable Cardiac Rhythm Management Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Implantable Cardiac Rhythm Management Devices Market

A detailed market share analysis in the Implantable Cardiac Rhythm Management Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Implantable Cardiac Rhythm Management Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Implantable Cardiac Rhythm Management Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Implantable Cardiac Rhythm Management Devices Market

A strategic analysis of the Implantable Cardiac Rhythm Management Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Implantable Cardiac Rhythm Management Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, BIOTRONIK SE & Co KG, Boston Scientific Corporation, Hydrix Limited, Japan Lifeline Co., Ltd., Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co., Ltd., Medtronic plc, MicroPort Scientific Corporation, and Stryker Corporation.

Market Segmentation & Coverage

This research report categorizes the Implantable Cardiac Rhythm Management Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Device, market is studied across Cardiac Resynchronization Therapy, Defibrillators, and Pacemakers. The Cardiac Resynchronization Therapy is further studied across CRT-Defibrillator and CRT-Pacemakers. The Defibrillators is further studied across External Defibrillator and Implantable Cardioverter Defibrillators. The Pacemakers is further studied across External and Implantable.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Hospitals, and Speciality Cardiac Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of cardiac diseases worldwide
      • 5.1.1.2. Favorable reimbursement policies
      • 5.1.1.3. Increasing adoption by the healthcare facilities
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of implantable cardiac rhythm management devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Surge in R&D spending and new product launches
      • 5.1.3.2. Integration of advanced technologies in CRM devices
    • 5.1.4. Challenges
      • 5.1.4.1. Operational issues associated with CRM devices
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Implantable Cardiac Rhythm Management Devices Market, by Device

  • 6.1. Introduction
  • 6.2. Cardiac Resynchronization Therapy
    • 6.2.1. CRT-Defibrillator
    • 6.2.2. CRT-Pacemakers
  • 6.3. Defibrillators
    • 6.3.1. External Defibrillator
    • 6.3.2. Implantable Cardioverter Defibrillators
  • 6.4. Pacemakers
    • 6.4.1. External
    • 6.4.2. Implantable

7. Implantable Cardiac Rhythm Management Devices Market, by End-User

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centers
  • 7.3. Hospitals
  • 7.4. Speciality Cardiac Centers

8. Americas Implantable Cardiac Rhythm Management Devices Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Implantable Cardiac Rhythm Management Devices Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Implantable Cardiac Rhythm Management Devices Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. BIOTRONIK SE & Co KG
  • 3. Boston Scientific Corporation
  • 4. Hydrix Limited
  • 5. Japan Lifeline Co., Ltd.
  • 6. Koninklijke Philips N.V.
  • 7. Lepu Medical Technology (Beijing) Co., Ltd.
  • 8. Medtronic plc
  • 9. MicroPort Scientific Corporation
  • 10. Stryker Corporation

LIST OF FIGURES

  • FIGURE 1. IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CRT-DEFIBRILLATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CRT-PACEMAKERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY SPECIALITY CARDIAC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 233. IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 234. IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023